Rocket Pharmaceuticals, Inc. general counsel Martin Wilson trims stake with $127,813 sale
53,389 shares sold on the open market on Nov 5, at about $2.39 each. Information only, not investment advice.
Insider selling at Rocket Pharmaceuticals, Inc.: Martin Wilson, a general counsel, sold 53,389 shares on Nov 5 for $127,813, at an average of $2.39 a share, a Form 4 filed on Nov 9 shows.
The filing does not mark the sale as made under a Rule 10b5-1 trading plan. The insider still holds 545,100 shares after the sale, 8.9% fewer than before.
The filing came 4 days after the trade.
Details from the SEC filing:
| Company | Rocket Pharmaceuticals, Inc. (RCKT) |
|---|---|
| Insider | Martin Wilson |
| Role | General Counsel |
| Transaction | Open-market sale (code S) |
| Shares | 53,389 |
| Average price | $2.39 |
| Value | $127,813 |
| Trade date | Nov 5, 2026 |
| Filed with the SEC | Nov 9, 2026, 4:05 PM ET |
| Shares held after | 545,100 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See this filing row by row in Insider Stock Trader
Browse the insider trading newsroom · Read the daily insider trading roundup
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.